Pfizer reports significant loss amid Paxlovid and vaccine challengesOctober 31, 2023 Pfizer, the pharmaceutical giant, revealed a significant quarterly loss for the third quarter, largely attributed to charges associated with the…
Pfizer’s COVID-19 medicine Paxlovid hits the market at a steep $1,400, sparking concernsOctober 20, 2023 Pharmaceutical giant Pfizer has announced its intention to charge $1,400 for a five-day course of its antiviral drug Paxlovid. This…
New study highlights potential of Pfizer’s oral weight loss drug as alternative to OzempicMay 22, 2023 A peer-reviewed study released on Monday reveals that an oral weight loss drug developed by Pfizer demonstrates similar efficacy and…
CDC recommends booster shots for COVID-19 strainsSeptember 2, 2022 In a positive move, the Centers for Disease Control and Prevention (CDC) recently endorsed updated COVID-19. This opens the door to…
